Early treatment failure in intermediate-risk
rhabdomyosarcoma: results from IRS-IV and D9803--a report from
the Children's Oncology Group.
Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2010 Sep 20: 4228-32
Randomized Phase II Window Trial of Two Schedules of
Irinotecan With Vincristine in Patients With First Relapse or
Progression of Rhabdomyosarcoma: A Report From the Children's
Oncology Group.
Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2010 Sep 13
Fusion-Negative Alveolar Rhabdomyosarcoma: Modification of
Risk Stratification Is Premature.
Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2010 Aug 9
Local Therapy for Rhabdomyosarcoma of the Hands and Feet:
Is Amputation Necessary? A Report from the Children's Oncology
Group.
International journal of radiation oncology,
biology, physics
, 2010 Jun 18
Regional Nodal Involvement and Patterns of Spread Along
In-transit Pathways in Children With Rhabdomyosarcoma of the
Extremity: A Report From the Children's Oncology Group.
International journal of radiation oncology,
biology, physics
, 2010 Jun 11
No evidence of a trial effect in newly diagnosed pediatric
acute lymphoblastic leukemia.
Archives of pediatrics & adolescent
medicine
, 2010 Mar: 214-7
Malignant progression in two children with multiple
osteochondromas.
Sarcoma
, 2010: 417105
Randomized trial and pharmacokinetic study of
pegfilgrastim versus filgrastim after dose-intensive chemotherapy
in young adults and children with sarcomas.
Clinical cancer research : an official journal
of the American Association for Cancer Research
, 2009 Dec 1: 7361-7
Pegfilgrastim for prevention of chemotherapy-associated
neutropenia in pediatric patients with solid tumors.
Pediatric blood &
cancer
, 2009 Sep: 375-8
Prognostic significance of tumor response at the end of
therapy in group III rhabdomyosarcoma: a report from the
children's oncology group.
Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2009 Aug 1: 3705-11
[F-18]-fluorodeoxy-D-glucose-positron emission tomography
response is associated with outcome for extremity osteosarcoma in
children and young adults.
Cancer
, 2009 Aug 1: 3519-25
COX-2 expression correlates with survival in patients with
osteosarcoma lung metastases.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2008 Jul: 507-12
Two boys with fragile x syndrome and hepatic
tumors.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2008 Mar: 239-41
Methemoglobinemia and hemolytic anemia caused by
rasburicase administration in a newly diagnosed child with
Burkitt lymphoma/leukemia.
Pediatric blood &
cancer
, 2008 Jan: 189
Delayed radiotherapy following dose intensive chemotherapy
for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
European journal of cancer (Oxford, England :
1990)
, 2007 Apr: 1045-50
Pediatric intradural extramedullary synovial sarcoma: case
report.
Neurosurgery
, 2006 Dec: E1339; discussion E1339
Topotecan by 21-day continuous infusion in children with
relapsed or refractory solid tumors: a Children's Oncology Group
study.
Pediatric blood &
cancer
, 2006 Nov: 790-4
Oral outpatient chemotherapy medication errors in children
with acute lymphoblastic leukemia.
Cancer
, 2006 Sep 15: 1400-6
Survival of tumor megaprostheses replacements about the
knee.
Clinical orthopaedics and related
research
, 2006 Sep: 39-45
[18F]Fluorodeoxyglucose positron emission tomography
predicts outcome for Ewing sarcoma family of tumors.
Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2005 Dec 1: 8828-34
Phase II trial of oral aminopterin for adults and children
with refractory acute leukemia.
Clinical cancer research : an official journal
of the American Association for Cancer Research
, 2005 Nov 15: 8089-96
Fas expression in lung metastasis from osteosarcoma
patients.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2005 Nov: 611-5
Survival after recurrence of Ewing's sarcoma family of
tumors.
Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2005 Jul 1: 4354-62
Metastatic malignant melanoma presenting as pancytopenia
in a three-year-old boy.
Pediatric blood &
cancer
, 2005 Jul: 60-3
Use of positron emission tomography in localized extremity
soft tissue sarcoma treated with neoadjuvant
chemotherapy.
Cancer
, 2005 Jan 15: 339-48
Transatlantic collaboration in pediatric oncology: now is
the time.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2004 Dec: 783-4
Toxicity and efficacy of intensive chemotherapy for
children with acute lymphoblastic leukemia (ALL) after first bone
marrow or extramedullary relapse.
Pediatric blood &
cancer
, 2004 Oct: 571-9
Asparaginase pharmacokinetics after intensive polyethylene
glycol-conjugated L-asparaginase therapy for children with
relapsed acute lymphoblastic leukemia.
Clinical cancer research : an official journal
of the American Association for Cancer Research
, 2004 Aug 15: 5335-41
Influence of age upon Ifosfamide-induced
nephrotoxicity.
Pediatric blood &
cancer
, 2004 May: 427-32
Fractionated low-dose radiotherapy after myeloablative
stem cell transplantation for local control in patients with
high-risk neuroblastoma.
Cancer
, 2004 Mar 15: 1268-75
Evaluation of early marrow response in childhood aneuploid
acute lymphoblastic leukemia: flow cytometric DNA analysis versus
standard morphology.
Pediatric and developmental pathology : the
official journal of the Society for Pediatric Pathology and the
Paediatric Pathology Society
, 2004 Jan-Feb: 39-47
Pattern of disease recurrence and prognostic factors in
patients with osteosarcoma treated with contemporary
chemotherapy.
Cancer
, 2003 Dec 1: 2447-56
Intensive induction chemotherapy and delayed irradiation
in the management of parameningeal rhabdomyosarcoma.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2003 Oct: 774-9
Prolonged survival after invasive aspergillosis: a
single-institution review of 11 cases.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2003 Apr: 286-91
Peripheral blood stem cell support reduces the toxicity of
intensive chemotherapy for children and adolescents with
metastatic sarcomas.
Cancer
, 2002 Sep 15: 1354-65
Treatment of metastatic osteosarcoma with the somatostatin
analog OncoLar: significant reduction of insulin-like growth
factor-1 serum levels.
Journal of pediatric hematology/oncology :
official journal of the American Society of Pediatric
Hematology/Oncology
, 2002 Aug-Sep: 440-6
Evaluation of chemotherapy response in pediatric bone
sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission
tomography.
Cancer
, 2002 Jun 15: 3277-84